Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2025-12-16 @ 9:28 PM
Study NCT ID:
NCT05814627
Status:
None
Last Update Posted:
2025-12-12 00:00:00
First Post:
2023-04-04 00:00:00
Brief Title:
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-04 00:00:00
First Submit QC Date:
April 4 2023
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-08 00:00:00
Last Update Post Date:
2025-12-12 00:00:00
Last Update Post Date Type:
ACTUAL